BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18240181)

  • 1. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
    Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
    Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of infliximab in a patient with neuro-Behçet's disease.
    Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
    Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
    Fujikawa K; Aratake K; Kawakami A; Aramaki T; Iwanaga N; Izumi Y; Arima K; Kamachi M; Tamai M; Huang M; Nakamura H; Nishiura Y; Origuchi T; Ida H; Eguchi K
    Ann Rheum Dis; 2007 Jan; 66(1):136-7. PubMed ID: 17178762
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of infliximab in progressive neuro-Behçet's syndrome.
    Kikuchi H; Aramaki K; Hirohata S
    J Neurol Sci; 2008 Sep; 272(1-2):99-105. PubMed ID: 18550081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
    Matsui T; Ishida T; Tono T; Yoshida T; Sato S; Hirohata S
    Mod Rheumatol; 2010 Dec; 20(6):621-6. PubMed ID: 20617356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome.
    Seyahi E; Hamuryudan V; Hatemi G; Melikoglu M; Celik S; Fresko I; Yurdakul S; Yazici H
    Rheumatology (Oxford); 2007 Jul; 46(7):1213-4. PubMed ID: 17478465
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
    Andreu M; Ramanoelina J; Fajnkuchen F; Mouthon L; Cohen P; Laroche L; Guillevin L
    Ann Med Interne (Paris); 2002 Oct; 153(6):414-5. PubMed ID: 12486393
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G; Velken M; Johnsen V
    Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

  • 10. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
    Connolly M; Armstrong JS; Buckley DA
    Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behçet's disease. Assessment with magnetic resonance of involvement of the central nervous system].
    Vilela P; Duarte J; Goulão A
    Acta Med Port; 2001; 14(1):113-6. PubMed ID: 11321965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab monotherapy for neuro-Behçet's disease: a case report.
    Di Filippo M; Di Gregorio M; Nannini C; Gaetani L; Gallina C; Floridi P; Sarchielli P; Calabresi P; Cantini F
    J Neurol Sci; 2014 Dec; 347(1-2):389-90. PubMed ID: 25456463
    [No Abstract]   [Full Text] [Related]  

  • 13. Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease.
    Rosenbaum JT
    J Rheumatol; 2004 Jul; 31(7):1241-3. PubMed ID: 15229938
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of infliximab on threatening panuveitis in Behçet's disease.
    Muñoz-Fernández S; Hidalgo V; Fernández-Melón J; Schlincker A; Martín-Mola E
    Lancet; 2001 Nov; 358(9293):1644. PubMed ID: 11716917
    [No Abstract]   [Full Text] [Related]  

  • 16. Worsening of osteomalacia in a patient successfully treated for neuro-Behçet's disease with infliximab.
    Madanat WY; Madanat AY
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S128-9. PubMed ID: 19026133
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Images: Entero-Behçet's disease.
    Kwok SK; Ju JH; Park KS; Park SH; Kim HY
    Arthritis Rheum; 2010 Apr; 62(4):1202. PubMed ID: 20131289
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-tumor necrotic factor antibody for treatment of neuro-Behçet's disease, a case report.
    Borhani Haghighi A; Safari A
    Clin Neurol Neurosurg; 2008 Mar; 110(3):315-6. PubMed ID: 18053588
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
    Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.